December 17, 2022
Taysha Gene Therapies Announces Executive Leadership Changes
Chair of the Board of Directors, Sean P. Nolan, appointed Chief Executive Officer Board Director, Sukumar Nagendran, M.D., appointed President…
Pharmaceuticals, Biotechnology and Life Sciences
Chair of the Board of Directors, Sean P. Nolan, appointed Chief Executive Officer Board Director, Sukumar Nagendran, M.D., appointed President…
New agreement leverages Sosei Heptares’ GPCR-focused structure-based drug design capabilities and Lilly’s extensive development, commercialization and therapeutic area expertiseSosei Heptares…
Experienced biotech executive to lead the next phase of growthADELAIDE, Australia, Dec. 15, 2022 (GLOBE NEWSWIRE) — Bionomics Limited (Nasdaq:…
Emraclidine is being developed as a potential once-daily treatment for schizophrenia without the need for titration Data show clinically meaningful…
VANCOUVER, British Columbia, Dec. 15, 2022 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader…
U.S. Food & Drug Administration (FDA) acknowledges the potential of OCU400 to treat rare inherited retinal diseasesMALVERN, Pa., Dec. 15,…
Transwestern Project Expected to Attract Life Sciences Jobs to Area Axiom Point Project Site Map of Vacaville identified the project…
Professor Jim DeKloe and Vacaville Councilmember Michael Silva Shake Hands Professor Jim DeKloe and Vacaville Councilmember Michael Silva shake hands…
EMERYVILLE, Calif., Dec. 15, 2022 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop…
NEW HAVEN, Conn., Dec. 14, 2022 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSXV:BTI) (OTCQB:BIOAF), (the “Company” or “Bioasis”), a multi-asset…